Table 2 Association between plasma chemerin concentration and all-cause as well as cause-specific mortality based on Cox proportional hazards regression models.

From: Association of plasma chemerin with all-cause and disease-specific mortality – results from a population-based study

Cause of death

# deaths/n

HR (95%-CI)

p-value

Analysis of all-cause mortality

All-cause

907/7422

1.17 (1.10; 1.26)

4.488E-06

Analysis of cause-specific mortality (considering competing risks)

All-cause

715/7230

1.18 (1.10; 1.28)

1.822E-05

CVD

248/7230

1.13 (0.99; 1.28)

6.394E-02

Cancer

257/7230

1.28 (1.13; 1.46)

1.242E-04

Other

210/7230

1.14 (0.99; 1.32)

6.817E-02

  1. The models were adjusted for sex, waist circumference, glycated hemoglobin, smoking status, and estimated glomerular filtration rate. The study cohort was included as a stratification variable. Participants’ age was used as time scale (unit: years). Chemerin was modeled as a continuous parameter (per 30 ng/mL [standard deviation]). Effect estimates were presented as hazard ratio (HR) together with its 95%-confidence interval (CI). Cause-specific hazards were modeled for each event separately and the respective competing events were considered as censored cases (cause-specific hazard function). CVD Cardiovascular disease.
Back to article page